• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT PT/INR CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT PT/INR CARTRIDGE Back to Search Results
Catalog Number 03P89-24
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Information (3190)
Event Date 06/26/2020
Event Type  malfunction  
Manufacturer Narrative
Apoc incident # (b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
 
Event Description
On (b)(6) 2020, abbott point of care was contacted by a customer regarding i-stat pt/inr cartridges that yielded a suspected discrepant pt/inr result of 2.5 on a (b)(6) year old female patient.The customer stated the patient came in with a mild cardio issue.Testing was performed to monitor the patient inr.The patient was not on coumadin or warfarin.There was no patient information available at the time of this report.Return product is not available for investigation.Method: i-stat, date: (b)(6) 2020, collected: 14:29, tested: 14:29, inr: 2.5.Lab/acl top, (b)(6) 2020, 14:33, 15:13, 1.0.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The patient is not on coumadin/warfarin and product was being used outside its intended use.The i-stat® pt/inr test is a whole blood determination of the prothrombin time used for monitoring oral anticoagulant (coumadin or warfarin) therapy.Reference cti sheet: prothrombin time pt/inr art: (b)(4).The investigation is underway.
 
Manufacturer Narrative
Apoc incident # (b)(4).The investigation was completed on 08/13/2020.A review of the device history record (dhr) confirmed that the cartridge lot passed release specifications.Retained cartridge testing met the acceptance criteria outlined in appendix 1 of q04.01.003 rev.Af (product complaint level 2 and level 3 investigation procedure).No deficiency has been identified.
 
Event Description
Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT PT/INR CARTRIDGE
Type of Device
PT/INR CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton, nj
MDR Report Key10271264
MDR Text Key198863953
Report Number2245578-2020-00076
Device Sequence Number1
Product Code GJS
UDI-Device Identifier10054749000170
UDI-Public10054749000170
Combination Product (y/n)N
PMA/PMN Number
K020355
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 08/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/14/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/22/2020
Device Catalogue Number03P89-24
Device Lot NumberS20055
Was Device Available for Evaluation? No
Date Manufacturer Received08/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age41 YR
-
-